16 – 30 of 59
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Cancer and Risk of COVID-19 Through a General Community Survey
(
- Contribution to journal › Article
-
Mark
Modest effects of dietary supplements during the COVID-19 pandemic : Insights from 445 850 users of the COVID-19 Symptom Study app
(
- Contribution to journal › Article
-
Mark
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
(
- Contribution to journal › Scientific review
-
Mark
Attributes and predictors of long COVID
(
- Contribution to journal › Article
-
Mark
Symptom clusters in COVID-19 : A potential clinical prediction tool from the COVID Symptom Study app
(
- Contribution to journal › Article
-
Mark
Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts
(
- Contribution to journal › Article
-
Mark
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
(
- Contribution to journal › Article
-
Mark
Genetic variation at RAB3GAP2 and its role in exercise-related adaptation and recovery
2021) p.1-16(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Aspirin and NSAID use and the risk of COVID-19
2021)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
På stark frammarsch i sjukvården
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality : a prospective study
(
- Contribution to journal › Article
-
Mark
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
(
- Contribution to journal › Article
-
Mark
Inhibition of NFAT signaling restores microvascular endothelial function in diabetic mice
(
- Contribution to journal › Article
-
Mark
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis : A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
(
- Contribution to journal › Article